Mutations in components in the PI3-kinase pathway have been reported as mutated in ∼40% in CRC [13], and analyses of the genomic landscape of CRC tumors have shown the PI3K pathway to be affected in a statistically significantly manner [14]. The gene discussed is PIK3CA; the disease is colorectal carcinoma.